ASCEND BY NTHRYS
Research Abroad Products

Pharmaceutical Biotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 217–228 of 260 project topics
Comparative Immunogenicity Risk Assessment Tool
A predictive analytics platform that leverages machine learning to assess immunogenicity risks and compare epitope profiles between biosimilars and reference biologics. This service enables manufacturers to optimize formulations pre-clinically and de-risk regulatory submissions, saving millions in failed development programs.
Biosimilar Development and Characterization Click to view more details →
Quality by Design Optimization Software for Biosimilar Manufacturing
An integrated QbD platform that models process parameters, identifies critical control points, and simulates manufacturing scale-up scenarios for consistent biosimilar production. This tool reduces manufacturing variability by 35% and enables robust regulatory dossiers, increasing commercial production margins.
Biosimilar Development and Characterization Click to view more details →
Regulatory Intelligence Dashboard for Biosimilar Pathway Navigation
A SaaS intelligence platform that aggregates real-time regulatory guidance, competitive biosimilar approvals, and pathway requirements across global markets. This service reduces regulatory strategy time and accelerates approval timelines by 6-12 months, enabling first-mover advantages in emerging markets.
Biosimilar Development and Characterization Click to view more details →
Formulation Stability Prediction Engine with Excipient Screening
An advanced computational chemistry platform that predicts degradation pathways and optimizes excipient combinations to match reference biologic stability profiles. This tool accelerates formulation development cycles by 60% and reduces failed stability studies, improving biosimilar product shelf-life economics.
Biosimilar Development and Characterization Click to view more details →
Size Exclusion Chromatography for Aggregation Analysis
Developing and validating SEC-HPLC methods for quantifying monomer content and aggregate levels in therapeutic protein formulations for quality control and stability testing.
Biologics Analytical Method Development Click to view more details →
Capillary Electrophoresis for Charge Variant Analysis
Developing capillary isoelectric focusing and capillary zone electrophoresis methods for resolving and quantifying acidic and basic charge variants of biologic drug substances.
Biologics Analytical Method Development Click to view more details →
Peptide Mapping for Primary Structure Confirmation
Developing LC-MS peptide mapping methods for confirming amino acid sequence, disulfide bond connectivity, and post-translational modifications of biopharmaceutical proteins.
Biologics Analytical Method Development Click to view more details →
Potency Assay Development for Biologics Release Testing
Designing and validating cell-based and binding potency assays that correlate with clinical efficacy for use as release and stability testing methods for biologic drug products.
Biologics Analytical Method Development Click to view more details →
Mass Spectrometry Platform for Intact Protein Characterization
Enterprise software platforms and instruments that enable real-time intact mass determination and heterogeneity profiling of therapeutic proteins and antibodies. This technology reduces time-to-market for biologics by 30-40% and commands premium licensing fees from pharmaceutical manufacturers requiring rapid release testing.
Biologics Analytical Method Development Click to view more details →
High-Performance Liquid Chromatography Service Bureau Solutions
Outsourced HPLC testing services and cloud-connected analytics platforms that automate method validation and stability testing for biologics manufacturers. Service-based models generate recurring revenue streams of $500K-$2M annually per customer while reducing internal laboratory infrastructure costs.
Biologics Analytical Method Development Click to view more details →
Flow Cytometry Software for Cell-Based Potency Assessment
AI-powered software tools and automated flow cytometry platforms that standardize and accelerate cell-based assays for CAR-T and monoclonal antibody potency testing. These solutions enable faster release decisions and support premium pricing strategies for biopharmaceutical developers requiring GMP-compliant data.
Biologics Analytical Method Development Click to view more details →
Spectroscopy Analytics Platform for Protein Stability Monitoring
Cloud-based data management platforms integrating UV-Vis, fluorescence, and circular dichroism spectroscopy for real-time protein stability and degradation pathway analysis. This digital transformation delivers predictive formulation optimization and reduces shelf-life testing timelines, enabling faster product launches worth millions in revenue acceleration.
Biologics Analytical Method Development Click to view more details →